Nominations & Governance Committee

The Nominations and Governance Committee oversees compliance and ensures our members are recognized nationally and internationally by nominating members for key internal and external prizes and positions.

We're growing!

Following a vote at the 2025 Annual General Meeting, the structure and composition of our governing committees and groups are changing.

We'll soon be recruiting new people into various leadership positions - check back soon for more information.

Narender Ramnani

President, Royal Holloway UoL

Professor Narender Ramnani is a Professor of Neuroscience and Vice Dean for Equity, Diversity, and Inclusion in the School of Life Sciences and the Environment, Royal Holloway.

Narender's research focuses on understanding brain systems and the mechanisms behind human behaviour, particularly the interactions between the frontal lobe and cerebellar plasticity. His work explores how these processes support cognitive and motor learning, using techniques such as functional MRI, eye tracking, and behavioral methods.

In addition to research, Prof Ramnani is passionate about research policy and sits on the UK Gov Parliamentary and Scientific Committee and Advance HE’s Race Equality Charter Governance Committee.

Julie Williams

President-Elect, University of Cardiff

Prof Julie Williams is a world leader in the genetics of Alzheimer’s disease and dementia and former Chief Scientific Advisor to the Welsh Government. She was the founding Centre Director for UK DRI at Cardiff from 2017-2024. With a background in Psychology, Julie obtained her PhD from the University of Wales Institute of Science and Technology. She joined University of Wales College of Medicine in 1991 as a Research Assistant, rising to Reader in Neuropsychological Genetics. As a co-lead in global initiatives her group has contributed to the discovery of over 40 susceptibility loci for AD. These findings implicate the role of immunity in disease development and specifically the contribution of microglia. Computational genetics of AD shows it to be a disease of multiple components which together, allow the prediction of those at high risk. Julie’s contribution to the field was recognised with a CBE in 2012. She is also an advocate for women in STEMM, commissioning a report that aimed to address the gender imbalance in science, published in 2016. Julie is also a member of the Council of the Academy of Medical Sciences and their champion in Wales.

Sarah King

Honorary Secretary, University of Sussex

Sarah is a molecular neuroscientist in the Biological and Clinical Neuroscience group in the School of Psychology and a member of Sussex Neuroscience. She obtained her BSc in Biology at the University of Bristol, followed by an MSc in Molecular Genetics and a PhD in Neuroscience at the University of Sussex. Sarah then went to Yale University where she worked as a postdoctoral associate in the Molecular Psychiatry Department for 7 years, before returning to a lecturership at Sussex. She was promoted to Reader in 2014.

Dani Wijesinghe

Membership & Communities Manager, British Neuroscience Association

Fiona Parker

Marketing & Communications Manager, British Neuroscience Association